Company History
Since 1980, we have analyzed more than 600 compounds to identify a promising compound for development as a cancer treatment for 30 years and developed new compound, As4O6, CHEMAS was established in 2000 and we are taking a step to obtain approval from relevant authorities for TetraAs.
2013 ~
| 2016.02 | Commence clinical trials in Europe |
| 2016.01 | Join in partnership with Korean medical doctors of Korean Medicine CHEMAS Network and educate about CHEMAS’s arsenic compounds |
| 2013 ~ | Finish pre-clinical trials and start process of new drug registration in China |
2001 ~ 2008
| 2008 | Conclude LOI with CRO for the process of clinical trial in Europe |
| 2007 | Obtain permission of phase II clinical trial |
| 2000 ~ 2004 | International application filed with PCT receiving office and national patent office. |
| 2004 ~ 2005 | Phase 1 Clinical trials |
| 2001 ~ 2002 | Pre-clinical trials |
1980 ~ 2000
| 1998 ~ 2000 | Patent registration relating to manufacture of TetraAs |
| 1997 ~ 1999 | Completed tests on efficacy and toxicity of new compound |
| 1989 ~ 1994 | Treat a number of patients with terminal cancer with new compound |
| 1980 ~ 1996 | Research and development of new compound to develop anti-cancer drug |